Gene · 55902
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation. | Cell Rep | 2025 | 40131933 | PubTator, text mining | PubMed |
| Impact of fasting and refeeding on immune markers, hepatic gene expression, and gut microbiota in geese: insights into metabolic regulation and gut-liver interactions. | Front Microbiol | 2025 | 40041863 | PubTator, text mining | PubMed |
| ACSS2 drives senescence-associated secretory phenotype by limiting purine biosynthesis through PAICS acetylation. | Nat Commun | 2025 | 40021646 | PubTator, text mining | PubMed |
| New strategies to enhance the efficiency and precision of drug discovery. | Front Pharmacol | 2025 | 40008135 | PubTator, text mining | PubMed |
| ACSS2 and metabolic diseases: from lipid metabolism to therapeutic target. | Lipids Health Dis | 2025 | 40001058 | PubTator, text mining | PubMed |
| Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets. | J Bone Oncol | 2025 | 39958756 | PubTator, text mining | PubMed |
| Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis. | Cell Rep | 2025 | 39932848 | PubTator, text mining | PubMed |
| Molecular Targets and Small Molecules Modulating Acetyl Coenzyme A in Physiology and Diseases. | ACS Pharmacol Transl Sci | 2025 | 39816789 | PubTator, text mining | PubMed |
| Novel arsenate-respiring bacteria drive arsenic biogeochemical cycling in Tibetan geothermal springs revealed by DNA-SIP based metagenomics. | J Hazard Mater | 2025 | 39689562 | PubTator, text mining | PubMed |
| Nutrient-driven histone code determines exhausted CD8+ T cell fates. | Science | 2025 | 39666821 | PubTator, text mining | PubMed |
| Decreased voluntary alcohol intake and ventral striatal epigenetic and transcriptional remodeling in male Acss2 KO mice. | Neuropharmacology | 2025 | 39653249 | PubTator, text mining | PubMed |
| α/β Hydrolases: Toward Unraveling Entangled Classification. | Proteins | 2025 | 39623291 | PubTator, text mining | PubMed |
| ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. | Cell Metab | 2025 | 39561764 | Swiss-Prot, curated | PubMed |
| Developmental trajectories of atopic dermatitis with multiomics approaches in the infant gut: COCOA birth cohort. | J Allergy Clin Immunol | 2025 | 39547281 | PubTator, text mining | PubMed |
| A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones. | Cell Metab | 2025 | 39471817 | PubTator, text mining | PubMed |
| Bempedoic acid suppresses diet-induced hepatic steatosis independently of ATP-citrate lyase. | Cell Metab | 2025 | 39471816 | PubTator, text mining | PubMed |
Inhibition of ACSS2 triggers glycolysis inhibition and nuclear translocation to activate SIRT1/ATG5/ATG2B deacetylation axis, promoting autophagy and reducing malignancy and chemoresistance in ovarian cancer. | Metabolism | 2025 | 39362518 | PubTator, text mining | PubMed |
| Sodium Crotonate Alleviates Diabetic Kidney Disease Partially Via the Histone Crotonylation Pathway. | Inflammation | 2025 | 38822951 | PubTator, text mining | PubMed |
| Acetate Metabolism in Urological Health and Disease. | Serican J Med | 2024 | 42111959 | PubTator, text mining | PubMed |
| Identification of a Potential PGK1 Inhibitor with the Suppression of Breast Cancer Cells Using Virtual Screening and Molecular Docking. | Pharmaceuticals (Basel) | 2024 | 39770478 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55902/papers?page=8